Biomedical Engineering Reference
In-Depth Information
[174] Mumper RJ, Wang J, Klakamp SL, Nitta H, Anwer A, Tagliaferri F, et al. Protective
interactive noncondensing (PINC) polymers for enhanced plasmid distribution and
expression in rat skeletal muscle. J Control Release 1998;52:191-203.
[175] Kabanov AV, Astafyeva IV, Chikindas ML, Rosenblat GF, Kiselev VI, Severin ES, et
al. DNA interpolyelectrolyte complexes as a tool for efficient cell transformation.
Biopolymers 1991;31:1437-43.
[176] Alila H, Coleman M, Nitta H, French M, Anwer K, Liu Q, et al. Expression of biologi-
cally active human insulin-like growth factor-I following intramuscular injection of a
formulated plasmid in rats. Hum Gene Ther 1997;8:1785-95.
[177] Anwer K, Shi M, French MF, Muller SR, Chen W, Liu Q, et al. Systemic effects of
human growth hormone after intramuscular injection of a single dose of muscle-specific
gene medicine. Hum Gene Ther 1998;9:659-70.
[178] Coleman M, Muller S, Quezada A, Mendiratta SK, Wang J, Thull NM, et al. Non-viral
interferon alpha gene therapy inhibits growth of established tumors by eliciting a sys-
temic immune response. Hum Gene Ther 1998;9:2223-30.
[179] Bishop JS, Thull NM, Matar M, Quezada A, Munger WE, Batten TL, et al. Antitumoral
effect of a non-viral interleukin-2 gene therapy is enhanced by combination with 5-fluo-
rouracil. Cancer Gene Ther 2000;7:1165-71.
[180] Mendiratta SK, Quezada A, Matar M, Wang J, Hebel HL, Long S, et al. Intratumoral
delivery of IL-12 gene by poly vinyl polymeric vector system to murine renal and colon
carcinoma results in potent antitumor immunity. Gene Ther 1999;6:833-9.
[181] Mendiratta SK, Quezada A, Matar M, Thull NM, Bishop JS, Nordstrom JL, et al.
Combination of interleukin 12 and interferon alpha gene therapy induces a synergistic
antitumor response against colon and renal cell carcinoma. Hum Gene Ther 2000;11:
1851-62.
[182] Wilson C, McKinney DM, Anders M, MaWhinney S, Forster J, Crimi C, et al.
Development of a DNA vaccine designed to induce cytotoxic T lymphocyte responses
to multiple conserved epitopes in HIV-1. J Immunol 2003;171:5611-23.
[183] Ishioka GY, Fikes J, Hermanson G, Livingston B, Crimi C, Qin M, et al. Utilization of
MHC Class I transgenic mice for development of minigene DNA vaccines encoding
multiple HLA-restricted CTL epitopes. J Immunol 1999;162:3915-25.
[184] Fraley R, Subramani S, Berg P, Papahadjopoulos D. Introduction of liposome-encapsu-
lated SV40 DNA into cells. J Biol Chem 1980;255:10431-5.
[185] Felgner PL, Gadek TR, Holm M, Roman R, Chan HW, Wenz M, et al. Lipofection: a
highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci USA
1987;84:7413-17.
[186] Gustafsson J, Arvidson G, Karlsson G, Almgren M. Complexes between cationic lipo-
somes and DNA visualized by cryo-TEM. Biochim Biophys Acta 1995;1235:305-12.
[187] Gershon H, Ghirlando R, Guttman SB, Minsky A. Mode of formation and structural
features of DNA-cationic liposome complexes used for transfection. Biochemistry
1993;32:7143-51.
[188] Felgner PL. Progress in gene delivery research and development. In: Huang L, Hung
M-C, Wagner E, editors. Non-viral vectors for gene therapy. San Diego, CA: Elsevier
Academic Press; 1999. p. 25-38.
[189] James MB, Giorgio TD. Nuclear-associated plasmid, but not cell associated plas-
mid, is correlated with transgene expression in cultured mammalian cells. Mol Ther
2000;1:339-46.
[190] Lechardeur D, Sohn KJ, Haardt M, Joshi PB, Monck M, Graham RW, et al. Metabolic
instability of plasmid DNA in the cytosol: a potential barrier to gene transfer. Gene Ther
1999;6:482-97.
Search WWH ::
Custom Search